196 related articles for article (PubMed ID: 28233295)
1. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.
Di Benedetto A; Ercolani C; Mottolese M; Sperati F; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Di Lauro L; Barba M; Vitale I; Ciliberto G; Speirs V; De Maria R; Maugeri-Saccà M
Sci Rep; 2017 Aug; 7(1):8078. PubMed ID: 28808232
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of PD-L1 in advanced gastric cancer is dependent on
Buglioni S; Melucci E; Sperati F; Pallocca M; Terrenato I; De Nicola F; Goeman F; Casini B; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vici P; Sergi D; Pizzuti L; Di Lauro L; Mazzotta M; Barba M; Fanciulli M; Vitale I; De Maria R; Ciliberto G; Maugeri-Saccà M
Oncoimmunology; 2018; 7(8):e1457602. PubMed ID: 30221053
[TBL] [Abstract][Full Text] [Related]
4. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
[TBL] [Abstract][Full Text] [Related]
5. DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.
Vici P; Buglioni S; Sergi D; Pizzuti L; Di Lauro L; Antoniani B; Sperati F; Terrenato I; Carosi M; Gamucci T; Dattilo R; Bartucci M; Vincenzoni C; Mariani L; Vizza E; Sanguineti G; Gadducci A; Vitale I; Barba M; De Maria R; Mottolese M; Maugeri-Saccà M
PLoS One; 2016; 11(3):e0149872. PubMed ID: 26930412
[TBL] [Abstract][Full Text] [Related]
6. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.
Jang SH; Lim JW; Morio T; Kim H
Free Radic Biol Med; 2012 Feb; 52(3):607-615. PubMed ID: 22178412
[TBL] [Abstract][Full Text] [Related]
7. DNA damage signaling is activated during cancer progression in human colorectal carcinoma.
Oka K; Tanaka T; Enoki T; Yoshimura K; Ohshima M; Kubo M; Murakami T; Gondou T; Minami Y; Takemoto Y; Harada E; Tsushimi T; Li TS; Traganos F; Darzynkiewicz Z; Hamano K
Cancer Biol Ther; 2010 Feb; 9(3):246-52. PubMed ID: 20023412
[TBL] [Abstract][Full Text] [Related]
8. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of irradiation-induced repair foci in mouse embryonic stem cells].
Suvorova II; Pospelov VA
Tsitologiia; 2014; 56(5):340-5. PubMed ID: 25696973
[TBL] [Abstract][Full Text] [Related]
11. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
Das S; Cardin D
Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
[TBL] [Abstract][Full Text] [Related]
14. ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.
Ray A; Blevins C; Wani G; Wani AA
PLoS One; 2016; 11(7):e0159344. PubMed ID: 27442013
[TBL] [Abstract][Full Text] [Related]
15. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
[TBL] [Abstract][Full Text] [Related]
16. Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
Barba M; Vici P; Pizzuti L; Di Lauro L; Sergi D; Di Benedetto A; Ercolani C; Sperati F; Terrenato I; Botti C; Mentuccia L; Iezzi L; Gamucci T; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M
BMC Cancer; 2017 Feb; 17(1):101. PubMed ID: 28166748
[TBL] [Abstract][Full Text] [Related]
17. Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer.
Gralewska P; Gajek A; Marczak A; Rogalska A
J Hematol Oncol; 2020 Apr; 13(1):39. PubMed ID: 32316968
[TBL] [Abstract][Full Text] [Related]
18. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
Yan S; Sorrell M; Berman Z
Cell Mol Life Sci; 2014 Oct; 71(20):3951-67. PubMed ID: 24947324
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
